Neuropharmacology

α-Synuclein Transgenic Mouse Model for Parkinson’s Disease - May, 2013

Among the myriad of hot topics discussed at the ADPD meeting this year in Florence, the aggregation and propagation of α-synuclein took the spotlight. For information on testing developmental compounds in an animal model reflecting the pathological features of Parkinson’s Disease, please click on the link below:

If you are interested in testing your drug candidate(s) in the APPSL mouse model exhibiting the characteristic inflammatory features of AD, please click on the link below:

back
top
20 years in pharma R&D navigation